Skip to main content
Year archive

NEUROONE MEDICAL TECHNOLOGIES Corp — 2026 filings

All 37 regulatory filings released by NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) in 2026, sourced directly from the official regulator.

37 Filings
2026 Period
2026 filings (37)
Filing Released Lang
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
Regulatory Filings
2026-05-28 English
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
Regulatory Filings
2026-05-22 English
CURRENT REPORT
Regulatory Filings
2026-05-22 English
10-Q - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Interim / Quarterly Report Q2 2026
2026-05-12 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-05-12 English
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
Earnings Release Q2 2026
2026-05-12 English
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
Regulatory Filings
2026-05-04 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-05-04 English
NeuroOne(R) Announces Chief Financial Officer Succession Plan
Board/Management Information
2026-04-30 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-04-30 English
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8:30 a.m. Eastern Time
Earnings Release Q2 2026
2026-04-28 English
NeuroOne(R) Advances Brain Drug Delivery Platform Through Collaboration With University of Minnesota
Regulatory Filings
2026-04-15 English
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
Share Issue/Capital Change
2026-04-14 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-04-14 English
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
Regulatory Filings
2026-04-03 English
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Share Issue/Capital Change
2026-04-02 English
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
Regulatory Filings
2026-03-26 English
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
Regulatory Filings
2026-03-17 English
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1:20 p.m. Eastern Time
Regulatory Filings
2026-03-11 English
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
Management Reports
2026-03-09 English
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
Board/Management Information
2026-03-03 English
4 - NEUROONE MEDICAL TECHNOLOGIES CORP (0001500198) (Filer)
Director's Dealing
2026-03-03 English
NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11:30 a.m. Eastern Time
Regulatory Filings
2026-02-26 English
8-K - NEUROONE MEDICAL TECHNOLOGIES CORP (0001500198) (Filer)
Regulatory Filings
2026-02-25 English
4 - NEUROONE MEDICAL TECHNOLOGIES CORP (0001500198) (Filer)
Director's Dealing
2026-02-20 English
4 - NEUROONE MEDICAL TECHNOLOGIES CORP (0001500198) (Filer)
Director's Dealing
2026-02-20 English
4 - NEUROONE MEDICAL TECHNOLOGIES CORP (0001500198) (Filer)
Director's Dealing
2026-02-20 English
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
Earnings Release Q1 2026
2026-02-17 English
10-Q Filing
Interim / Quarterly Report Q1 2026
2026-02-17 English
8-K Filing
Regulatory Filings
2026-02-17 English
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8:30 a.m. Eastern Time
Report Publication Announcement
2026-02-04 English
10-K/A Filing
Annual Report FY 2025
2026-01-23 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-05 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-05 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-05 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-02 English
PRIMARY DOCUMENT
Director's Dealing
2026-01-02 English